Trial Profile
Safety and tolerability of escalating single doses of the hepatitis B virus RNA interference drug ARC- 521 in a healthy volunteer population
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 07 Jul 2017
Price :
$35
*
At a glance
- Drugs ARC 521 (Primary)
- Indications Unspecified
- Focus Adverse reactions
- 07 Jul 2017 New trial record